Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Our study aims to determine the efficacy of ultrasound and EMG guided Botox injections into
the puborectalis muscle in women with non-relaxing puborectalis syndrome. With use of this
technique, we believe we will find that Botox injections decrease symptom severity and
improve quality of life (QOL) in patients with NRPS. All enrolled patients will receive
ultrasound and EMG guided Botox injections at three points along the puborectalis muscle.
Post-injection data will be obtained with a defecation diary and questionnaire data at the
2-week, 3-month, and 6-month intervals.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Karen Noblett University of California, Irvine
Collaborators:
Allergan American Urogynecologic Society
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA